TVRD
Tvardi Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.92
+0.25 ▲ +6.67%
🌙 3월 13일 5:11 PM ET (한국 3/14 06:11)
$3.92
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -9.85 | Insider Own | 30.22% | Shs Outstand | 0.01B | Perf Week | -0.25% |
| Market Cap | 0.04B | Forward P/E | - | EPS next Y | -54.28% | Insider Trans | - | Shs Float | 0.01B | Perf Month | 3.7% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | -0.59 | Inst Own | 30.15% | Short Float | 9.72% | Perf Quarter | -13.47% |
| Income | -0.01B | P/S | 9.15 | EPS this Y | 2.51% | Inst Trans | 3.02% | Short Ratio | 7.54 | Perf Half Y | -88.93% |
| Sales | 0.00B | P/B | 1.32 | EPS next 5Y | -28.05% | ROA | -30.87% | Short Interest | 0.64M | Perf YTD | -8.84% |
| Book/sh | 2.97 | P/C | 1.01 | EPS past 3/5Y | 9.46% 12.29% | ROE | -97.61% | 52W High | -91.02% ($43.65) | Perf Year | -74.18% |
| Cash/sh | 3.89 | P/FCF | - | Sales past 3/5Y | -32.33% -18.53% | ROIC | -49.84% | 52W Low | 12% ($3.50) | Perf 3Y | -98.13% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 86.75% | Gross Margin | - | Volatility(W/M) | 5.62% 6.43% | Perf 5Y | -99.44% |
| Dividend TTM | - | EV/Sales | 0.13 | Sales Y/Y TTM | -53.67% | Oper. Margin | -576.39% | ATR (14) | 0.24 | Perf 10Y | -97.71% |
| Dividend Ex-Date | - | Quick Ratio | 3.48 | EPS Q/Q | 92.8% | Profit Margin | -346.55% | RSI (14) | 50.25 | Recom | 1.67 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.48 | Sales Q/Q | -100% | SMA20 | 2.33% ($3.83) | Beta | 0.08 | Target Price | $9.4 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2026/03/03 | SMA50 | -2.96% ($4.04) | Rel Volume | 0.57 | Prev Close | $3.67 |
| Employees | 10 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 13.66% - | SMA200 | -75.51% ($16.01) | Avg Volume(3M) | 0.08M | Price | $3.92 |
| IPO | 2014/1/31 | Option/Short | Yes/Yes | Trades | 813 | Volume | 47,898 | Change | 6.67% |
뉴스 로딩 중...